Vident Advisory’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
96,208
+10,005
+12% +$2.08M 0.16% 115
2026
Q1
$18.2M Buy
86,203
+106
+0.1% +$22.8K 0.16% 117
2025
Q4
$17.7M Buy
86,097
+13,919
+19% +$2.62M 0.16% 114
2025
Q3
$11.3M Buy
72,178
+18,554
+35% +$2.87M 0.11% 176
2025
Q2
$9.01M Buy
53,624
+17,329
+48% +$2.57M 0.1% 175
2025
Q1
$5M Buy
36,295
+29,194
+411% +$3.72M 0.07% 235
2024
Q4
$840K Buy
7,101
+247
+4% +$28.8K 0.01% 704
2024
Q3
$758K Buy
6,854
+773
+13% +$80.8K 0.02% 736
2024
Q2
$598K Sell
6,081
-140,896
-96% -$14.4M 0.02% 796
2024
Q1
$16.4M Buy
146,977
+142,080
+2,901% +$15.3M 0.34% 77
2023
Q4
$494K Buy
4,897
+564
+13% +$56K 0.01% 780
2023
Q3
$376K Buy
+4,333
New +$392K 0.01% 800

Other funds holding CAH

Vident Advisory's CAH Position: Q2 2026 in Review

Vident Advisory increased its Cardinal Health (CAH) stake by 12% in Q2 2026, buying an estimated $2.08M and bringing the position to 96,208 shares worth $22.9M. The position accounts for 0.16% of the portfolio, ranked #115.

Vident Advisory first reported a position in CAH in Q3 2023 and has held it in 12 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Vident Advisory held 96,208 shares of Cardinal Health worth $22.9M as of Q2 2026.
  • Vident Advisory bought 10,005 Cardinal Health shares in Q2 2026, an estimated $2.08M.
  • Cardinal Health made up 0.16% of Vident Advisory's portfolio in Q2 2026, its #115 holding.
  • Vident Advisory first reported a position in Cardinal Health in Q3 2023 and has held it in 12 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.